Disease: Myelodysplastic syndromes
- A case of Bloom syndrome manifesting with therapy-related myelodysplastic syndromes harboring a novel BLM gene variant
- A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias
- Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation
- Acute lymphoblastic leukemia with pseudo-Chediak-Higashi granules in the initial diagnosis and relapse
- Adding the epigenomic signature to the prognostic jigsaw of myelodysplastic neoplasm?
- Analyzing Blood Cells of High-Risk Myelodysplastic Syndrome Patients Using Interferometric Phase Microscopy and Fluorescent Flow Cytometry
- Anesthetic Management of a Patient with MIRAGE Syndrome: A Case Report
- Autoimmune diseases and myelodysplastic syndromes
- C5 inhibition in PNH: still effective and safe
- Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopenias
- Case report: A successful clinical experience of transplantation of liver and kidney from a donor with myelodysplastic syndromes
- Case report: Therapy-related myeloid neoplasms in three pediatric cases with medulloblastoma
- Caspase 8 deletion causes infection/inflammation-induced bone marrow failure and MDS-like disease in mice
- Characterization of CD34(+) Cells from Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Using a t-Distributed Stochastic Neighbor Embedding (t-SNE) Protocol
- Chidamide Promotes Osteogenic Differentiation of Bone Marrow Mesenchymal Stromal Cells from Patients with Myelodysplastic Syndromes
- Chromatin Organization in Myelodysplastic Syndrome
- Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management
- Classic paroxysmal nocturnal haemoglobinuria presenting with intestinal malabsorption syndrome, acute abdomen and acute kidney injury
- Clinical activity, pharmacokinetics, and pharmacodynamics of oral hypomethylating agents for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: A multidisciplinary review
- CLO24-054: Treatment Outcomes in VEXAS Syndrome in Patients With MDS: A Systematic Review
- CLO24-079: Results From Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion Dependent (RBC-TD) Non-del(5q) Lower-Risk Myelodysplastic Syndromes (LR-MDS) Relapsed/Refractory to/Ineligible for Eryt
- Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with DDX41 mutations
- Comparative analysis of feature-based ML and CNN for binucleated erythroblast quantification in myelodysplastic syndrome patients using imaging flow cytometry data
- Comparison of cytomorphology and histomorphology in myelodysplastic syndromes
- Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms
- Comprehensive study of chromosomal CNVs and genomic variations predicting overall survival in Myelodysplastic syndromes
- Construction and experimental validation of a novel ferroptosis-related gene signature for myelodysplastic syndromes
- Correction to "Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies"
- Deconvoluting the Complexity of Congenital Sideroblastic Anemias through Genetic and Functional Profiling
- Discerning clinicopathological features of congenital neutropenia syndromes: an approach to diagnostically challenging differential diagnoses
- DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study
- Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French-Italian Experience of 134 Patients
- Down-regulation of A20 mRNA expression in peripheral blood mononuclear cells from MDS patients
- Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes
- Eculizumab in patients with paroxysmal nocturnal hemoglobinuria: a real-world study in China
- Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in the treatment of secondary acute myeloid leukemia
- Efficacy and safety analysis of venetoclax combined with hypomethylating agents for the treatment of higher-risk myelodysplastic syndromes in the real world
- Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA-JMML-001 trial
- Expert consensus on clonal screening and monitoring of complement inhibitor therapy in paroxysmal nocturnal hemoglobinuria (2024)
- EXPRESS: A new therapeutic perspective: erastin inhibits tumor progression by driving ferroptosis in myelodysplastic syndromes
- First-in-human study of JNJ-67571244, a CD33 CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome
- Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms
- Germline MYOF1::WNK4 and VPS25::MYOF1 Chimeras Generated by the Constitutional Translocation t(17;19)(q21;p13) in Two Siblings With Myelodysplastic Syndrome
- Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders
- Glycolytic activity and in vitro effect of the pyruvate kinase activator AG-946 in red blood cells from low-risk myelodysplastic syndromes patients: A proof-of-concept study
- Growth Charts for Shwachman-Diamond Syndrome at Ages 0 to 18 Years
- Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes
- HSPA9/mortalin inhibition disrupts erythroid maturation through a TP53-dependent mechanism in human CD34+ hematopoietic progenitor cells
- HSR24-132: Value of Early Transfusion Burden Reduction in Lower-Risk Myelodysplastic Syndromes (LR-MDS)
- HSR24-133: Real-World (RW) Effectiveness of Erythropoiesis-Stimulating Agents (ESAs) After Luspatercept in Patients (pts) With Myelodysplastic Syndromes (MDS): A Retrospective Analysis of a Large Healthcare Claims Database in the United States
- HSR24-142: Real-World Clinical Benefit Among Patients (pts) With Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated With Luspatercept
- HSR24-159: Relationship Between Durable Transfusion Independence (TI) and Survival Outcomes in Patients (Pts) With Lower-Risk Myelodysplastic Syndrome (LR-MDS): An Analysis From US Health Insurance Claims Data
- Imetelstat: Finally a disease-modifying treatment for lower-risk myelodysplastic syndromes?
- Impact of Lactate Dehydrogenase and Hemoglobin Levels on Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From the National Korean PNH Registry
- Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation
- Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine
- Is hematological cytology outdated at the age of molecular biology and flow cytometry ? Report of a VEXAS syndrome clinical case
- Is There any Relationship Between the Repeated Complications of Sickle Cell Disease and the Potential Development of Acute Leukemia?
- Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes
- Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms
- Luspatercept in low-risk myelodysplastic syndromes: a paradigm shift in treatment strategies
- Management of paroxysmal nocturnal hemoglobinuria in CALR mutated post-essential thrombocythemia myelofibrosis: A case report
- Molecular responses in decitabine- and decitabine/venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromes
- Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or SF3B1 Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review
- Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape
- Myelodysplastic syndrome with IgG4-related disease: A case report
- Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome
- Optimal Treatment Approaches to Intestinal Behcet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
- Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study
- Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria
- p53 immunohistochemistry as an ancillary tool for rapid assessment of residual disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes
- Phenotypic Analysis of Hematopoietic Stem and Progenitor Cell Populations in Acute Myeloid Leukemia Based on Spectral Flow Cytometry, a 20-Color Panel, and Unsupervised Learning Algorithms
- PMDA regulatory update on approval of new drugs and revisions of precautions; approval of talazoparib tosilate for prostate and breast cancer, and luspatercept for myelodysplastic syndrome in Japan
- Prevalence of massively diluted bone marrow cell samples aspirated from patients with myelodysplastic syndromes (MDS) or suspected of MDS: A retrospective analysis of nationwide samples in Japan
- Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases
- Rapid progression from MDS to AML with gastric submucosal tumour as an extramedullary infiltration
- Rare Hematologic Malignancies and Pre-Leukemic Entities in Children and Adolescents Young Adults
- Real-World Outcome and Prognostic Factors in MDS Patients Treated with Azacitidine-A Retrospective Analysis
- Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression
- Revisiting the most often used item in the haematological tool box-The extent of haemodilution in bone marrow aspirates
- Role of reactive oxygen species in myelodysplastic syndromes
- Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study
- Safety Profile of Monoclonal Antibodies and Subsequent Drug Developments in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
- Single-cell transcriptomics dissects the transcriptome alterations of hematopoietic stem cells in myelodysplastic neoplasms
- SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes
- Study of a patient with Myelodysplastic/myeloproliferative neoplasm with co-morbid neutrophilia and a novel NCOR1::GLYR1 fusion gene
- Survival and Prognosis of Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes Transformed from Myelodysplastic Syndrome
- The immunologic abnormalities in patients with paroxysmal nocturnal hemoglobinuria are associated with disease progression
- The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation
- The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults
- Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities
- Treatment patterns and outcomes with luspatercept in patients with lower-risk myelodysplastic syndromes: A retrospective US cohort analysis
- Treatment-emergent mutations in myelodysplastic syndrome with del(5q) - lenalidomide related or disease-intrinsic clonal evolution?
- Treosulfan (Trecondyv): CADTH Reimbursement Recommendation: Indication: Treosulfan in combination with fludarabine as part of conditioning treatment prior to allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia
- Tripartite prehabilitation of patients with acute myeloid leukaemia and high-risk myelodysplastic syndromes during intensive chemotherapy before allogeneic haematopoietic stem cell transplantation (COHABILIT): protocol for an innovating prospective multic
- Unveiling the clinical spectrum of relapsing polychondritis: insights into its pathogenesis, novel monogenic causes, and therapeutic strategies
- Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS-SFB31
- Venetoclax Combination Treatment of Acute Myeloid Leukemia in Adolescents and Young Adult Patients
- VEXAS syndrome presenting as diffuse alveolar haemorrhage
- VEXAS syndrome: A review of cutaneous findings and treatments in an emerging autoinflammatory disease